Expert suspects causal link between AstraZeneca jab and rare blood clots

UK regulators said they had identified 30 cases of rare blood clot events out of 18.1 million doses of the jab (PA)

The evidence is shifting towards a causal link between rare blood clots and the Oxford/AstraZeneca Covid-19 vaccine, according to an expert.

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) said it had identified 30 cases of rare blood clot events out of 18.1 million doses of the jab administered up to and including March 24.